A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Celecoxib Impurity 17 | CAS 75877-78-0 - Request Quote

Picture of Celecoxib Impurity 17

Celecoxib Impurity 17

SZ CAT No:SZ-C005027
CAS No
75877-78-0
Mol.F.
C6H4ClN2
Mol.Wt.
139.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Celecoxib Impurity 17 is chemically (4-Chlorophenylazo)radical. Celecoxib Impurity 17 is supplied with detailed characterization data compliant with regulatory guideline. Celecoxib Impurity 17 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Celecoxib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 75877-78-0

Purchase 75877-78-0

Order 75877-78-0

Enquire 75877-78-0

price of 75877-78-0

75877-78-0 Supplier

75877-78-0 Manufacturer

75877-78-0 Exporter

buy high quality Celecoxib Impurity 17

Purchase Celecoxib Impurity 17

Celecoxib Impurity 17 suppliers

Celecoxib Impurity 17 manufacturers

Celecoxib Impurity 17 price

Order Celecoxib Impurity 17

Enquire Celecoxib Impurity 17

Celecoxib Impurity 17 cost

Celecoxib Impurity 17 Supplier

Celecoxib Impurity 17 Distributor

Celecoxib Impurity 17 for Method Validation

Celecoxib Reference Standard

Celecoxib Impurity 17 for ANDA Filing

Celecoxib Impurity 17 for Forced Degradation Studies

Celecoxib Impurity 17 Identification Standards

Celecoxib Impurity 17 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,